Vineet Laboratories Limited (NSE:VINEETLAB)
38.55
+2.11 (5.79%)
Apr 29, 2026, 3:29 PM IST
Vineet Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 545.86 | 749.95 | 1,506 | 2,123 | 1,912 | 2,435 | Upgrade
|
| Other Revenue | 14.27 | 19.58 | 3.73 | - | - | - | Upgrade
|
| Revenue | 560.13 | 769.53 | 1,510 | 2,123 | 1,912 | 2,435 | Upgrade
|
| Revenue Growth (YoY) | -43.36% | -49.03% | -28.89% | 11.05% | -21.48% | - | Upgrade
|
| Cost of Revenue | 496.17 | 730.76 | 1,181 | 1,761 | 1,497 | 2,000 | Upgrade
|
| Gross Profit | 63.96 | 38.77 | 329.08 | 361.93 | 414.24 | 434.54 | Upgrade
|
| Selling, General & Admin | 42.83 | 53.75 | 64.83 | 60.71 | 58.31 | 56.38 | Upgrade
|
| Other Operating Expenses | 57.48 | 128.27 | 188.52 | 227.99 | 224.31 | 296.59 | Upgrade
|
| Operating Expenses | 125.64 | 207.04 | 278.54 | 312.43 | 302.78 | 371.04 | Upgrade
|
| Operating Income | -61.69 | -168.27 | 50.54 | 49.5 | 111.46 | 63.5 | Upgrade
|
| Interest Expense | -46.47 | -38.31 | -38.49 | -26.58 | -14.89 | -26.67 | Upgrade
|
| Interest & Investment Income | - | - | 0.35 | 1.23 | 1.62 | 0.46 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.07 | 3.37 | 0.92 | 2.74 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.47 | -1.47 | -9.32 | -7.22 | -5.65 | 0.54 | Upgrade
|
| EBT Excluding Unusual Items | -109.58 | -208 | 3.15 | 20.3 | 93.46 | 40.58 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.25 | 0.25 | 0.48 | - | - | - | Upgrade
|
| Pretax Income | -109.33 | -207.76 | 3.63 | 20.3 | 93.46 | 40.58 | Upgrade
|
| Income Tax Expense | -7.94 | -5.85 | -6.64 | 7.77 | 27.07 | 22.78 | Upgrade
|
| Net Income | -101.39 | -201.91 | 10.27 | 12.53 | 66.39 | 17.8 | Upgrade
|
| Net Income to Common | -101.39 | -201.91 | 10.27 | 12.53 | 66.39 | 17.8 | Upgrade
|
| Net Income Growth | - | - | -18.00% | -81.13% | 272.89% | - | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | -0.17% | - | - | - | - | 2148.54% | Upgrade
|
| EPS (Basic) | -11.04 | -21.90 | 1.11 | 1.36 | 7.20 | 1.93 | Upgrade
|
| EPS (Diluted) | -11.04 | -21.90 | 1.11 | 1.36 | 7.20 | 1.93 | Upgrade
|
| EPS Growth | - | - | -18.30% | -81.13% | 272.84% | - | Upgrade
|
| Free Cash Flow | - | 104.46 | -94 | -172.5 | 76.32 | 274.86 | Upgrade
|
| Free Cash Flow Per Share | - | 11.33 | -10.20 | -18.71 | 8.28 | 29.81 | Upgrade
|
| Dividend Per Share | - | - | - | - | 1.000 | - | Upgrade
|
| Gross Margin | 11.42% | 5.04% | 21.80% | 17.05% | 21.67% | 17.85% | Upgrade
|
| Operating Margin | -11.01% | -21.87% | 3.35% | 2.33% | 5.83% | 2.61% | Upgrade
|
| Profit Margin | -18.10% | -26.24% | 0.68% | 0.59% | 3.47% | 0.73% | Upgrade
|
| Free Cash Flow Margin | - | 13.57% | -6.23% | -8.13% | 3.99% | 11.29% | Upgrade
|
| EBITDA | -36.8 | -143.25 | 75.73 | 73.23 | 131.62 | 81.57 | Upgrade
|
| EBITDA Margin | -6.57% | -18.62% | 5.02% | 3.45% | 6.88% | 3.35% | Upgrade
|
| D&A For EBITDA | 24.89 | 25.02 | 25.19 | 23.73 | 20.16 | 18.07 | Upgrade
|
| EBIT | -61.69 | -168.27 | 50.54 | 49.5 | 111.46 | 63.5 | Upgrade
|
| EBIT Margin | -11.01% | -21.87% | 3.35% | 2.33% | 5.83% | 2.61% | Upgrade
|
| Effective Tax Rate | - | - | - | 38.30% | 28.97% | 56.13% | Upgrade
|
| Revenue as Reported | 560.41 | 769.82 | 1,511 | 2,124 | 1,915 | 2,439 | Upgrade
|
| Advertising Expenses | - | 0.05 | 0.59 | 0.5 | 0.75 | 0.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.